Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $260.64 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $72.82 | 3 | $0 (2023) |
| ITI, Inc. | $55.94 | 1 | $0 (2022) |
| Lilly USA, LLC | $29.31 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $24.84 | 2 | $0 (2023) |
| Merck Sharp & Dohme LLC | $23.10 | 1 | $0 (2022) |
| ABBVIE INC. | $15.14 | 1 | $0 (2023) |
| Amgen Inc. | $14.47 | 1 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $13.03 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $11.99 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $98.94 | 6 | Lilly USA, LLC ($29.31) |
| 2022 | $130.18 | 5 | ITI, Inc. ($55.94) |
| 2021 | $31.52 | 2 | Neurocrine Biosciences, Inc. ($19.53) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/26/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: Neuropsychiatry | ||||||
| 04/24/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: PSYCHIATRY | ||||||
| 03/22/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/28/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Diabetes | ||||||
| 01/23/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Diabetes | ||||||
| 12/09/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Neuropsychiatry | ||||||
| 10/25/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/18/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/16/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Inflammation | ||||||
| 04/12/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $55.94 | General |
| Category: PSYCHIATRY | ||||||
| 08/03/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: Neuroscience | ||||||
| 04/06/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 11 | 294 | 7,106 | $422,182 | $84,882 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1955 | Injection, levocarnitine, per 1 gm | Office | 2020 | 32 | 1,330 | $117,266 | $22,174 | 18.9% |
| 97112 | Therapeutic procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2020 | 33 | 822 | $61,650 | $17,790 | 28.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 34 | 1,677 | $92,400 | $16,587 | 18.0% |
| J3415 | Injection, pyridoxine hcl, 100 mg | Office | 2020 | 34 | 1,681 | $76,942 | $10,639 | 13.8% |
| J3490 | Unclassified drugs | Office | 2020 | 16 | 316 | $17,290 | $4,372 | 25.3% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 27 | 27 | $9,126 | $3,642 | 39.9% |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | Office | 2020 | 33 | 397 | $10,775 | $2,840 | 26.4% |
| 97016 | Application of blood vessel compression or decompression device to 1 or more areas | Office | 2020 | 33 | 410 | $14,350 | $2,740 | 19.1% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 22 | 77 | $5,775 | $2,447 | 42.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 16 | $2,400 | $838.08 | 34.9% |
| J3411 | Injection, thiamine hcl, 100 mg | Office | 2020 | 15 | 353 | $14,208 | $813.81 | 5.7% |
About Ame Wells, FNP
Ame Wells, FNP is a Registered Nurse healthcare provider based in Kalispell, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/08/2020. The National Provider Identifier (NPI) number assigned to this provider is 1912547845.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ame Wells, FNP has received a total of $260.64 in payments from pharmaceutical and medical device companies, with $98.94 received in 2023. These payments were reported across 13 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($260.64).
As a Medicare-enrolled provider, Wells has provided services to 294 Medicare beneficiaries, totaling 7,106 services with total Medicare billing of $84,882. Data is available for 1 year (2020–2020), covering 11 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Family
- Location Kalispell, MT
- Active Since 01/08/2020
- Last Updated 03/11/2020
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1912547845
Products in Payments
- INGREZZA (Drug) $72.82
- CAPLYTA (Drug) $55.94
- MOUNJARO (Drug) $29.31
- FARXIGA (Drug) $24.84
- VERQUVO (Drug) $23.10
- VRAYLAR (Drug) $15.14
- Otezla (Drug) $14.47
- REXULTI (Drug) $13.03
- INVEGA SUSTENNA (Drug) $11.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Kalispell
Sonya Milheim, Pmhnp, PMHNP
Registered Nurse — Payments: $470.12
Kendall Babb, Acnp-Bc, ACNP-BC
Registered Nurse — Payments: $118.09
Mrs. Kathleen Olson, Np, NP
Registered Nurse
Jennifer Boulden, Rn, RN
Registered Nurse
Colleen Karper, Rn, RN
Registered Nurse
Mr. James Simpach
Registered Nurse